#BEGIN_DRUGCARD DB01857

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C4H8NO7P

# Chemical_IUPAC_Name:
(2S)-2-amino-4-oxo-4-(phosphonooxy)butanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Phosphoaspartate

# HET_ID:
PHD

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H8NO7P/c5-2(4(7)8)1-3(6)12-13(9,10)11/h2H,1,5H2,(H,7,8)(H2,9,10,11)/t2-/m0/s1

# InChI_Key:
InChIKey=IXZNKTPIYKDIGG-REOHCLBHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1857

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
213.0826

# Molecular_Weight_Mono:
213.003838127

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1D5W
1K68
1LVH

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.9

# Predicted_LogS:
-1.2

# Predicted_Water_Solubility:
1.32e+01 g/l

# Primary_Accession_No:
DB01857

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
152441

# PubChem_Substance_ID:
46506289

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
DB03713
DB04247
EXPT00574

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CC(=O)OP(O)(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:33 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Z70730

# Drug_Target_1_GenBank_ID_Protein:
1495997

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
pgmB

# Drug_Target_1_Gene_Sequence:
>666 bp
ATGTTTAAAGCAGTATTGTTTGATTTAGATGGTGTAATTACAGATACCGCAGAGTATCAT
TTTAGAGCTTGGAAAGCTTTGGCTGAAGAAATTGGCATTAATGGTGTTGACCGCCAATTT
AATGAGCAATTAAAAGGGGTCTCACGAGAAGACTCGCTTCAGAAAATTCTAGATTTAGCT
GATAAAAAAGTATCAGCTGAGGAATTTAAAGAACTTGCTAAGAGAAAAAATGATAACTAT
GTGAAAATGATTCAGGATGTGTCGCCAGCCGATGTCTATCCTGGAATTTTACAATTACTC
AAAGATTTACGTTCAAATAAAATCAAAATTGCTTTAGCGTCGGCTTCTAAGAATGGTCCA
TTTTTATTAGAGAGAATGAATTTAACTGGATATTTTGATGCAATTGCTGATCCGGCTGAA
GTTGCAGCATCAAAACCAGCACCAGATATTTTTATTGCAGCAGCACATGCAGTGGGTGTT
GCCCCCTCTGAATCAATTGGGTTAGAGGATTCTCAAGCTGGAATTCAAGCCATCAAAGAT
TCAGGGGCTTTACCAATTGGTGTAGGGCGCCCAGAAGATTTGGGAGATGATATCGTCATT
GTGCCTGATACTTCACACTATACATTAGAATTTTTGAAAGAAGTTTGGCTTCAAAAGCAA
AAATAA

# Drug_Target_1_General_Function:
Involved in phosphoglucomutase activity

# Drug_Target_1_General_References:
11337471	Bolotin A, Wincker P, Mauger S, Jaillon O, Malarme K, Weissenbach J, Ehrlich SD, Sorokin A: The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 2001 May;11(5):731-53.
9084169	Qian N, Stanley GA, Bunte A, Radstrom P: Product formation and phosphoglucomutase activities in Lactococcus lactis: cloning and characterization of a novel phosphoglucomutase gene. Microbiology. 1997 Mar;143 ( Pt 3):855-65.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2476

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
24209

# Drug_Target_1_Name:
Beta-phosphoglucomutase

# Drug_Target_1_Number_of_Residues:
221

# Drug_Target_1_PDB_ID:
1Z4O

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00702	Hydrolase

# Drug_Target_1_Protein_Sequence:
>Beta-phosphoglucomutase
MFKAVLFDLDGVITDTAEYHFRAWKALAEEIGINGVDRQFNEQLKGVSREDSLQKILDLA
DKKVSAEEFKELAKRKNDNYVKMIQDVSPADVYPGILQLLKDLRSNKIKIALASASKNGP
FLLEKMNLTGYFDAIADPAEVAASKPAPDIFIAAAHAVGVAPSESIGLEDSQAGIQAIKD
SGALPIGVGRPEDLGDDIVIVPDTSYYTLEFLKEVWLQKQK

# Drug_Target_1_Reaction:
beta-D-glucose 1-phosphate = beta-D-glucose 6-phosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Reversible transformation of glucose 6-phosphate and beta-glucose 1-phosphate

# Drug_Target_1_SwissProt_ID:
P71447

# Drug_Target_1_SwissProt_Name:
PGMB_LACLA

# Drug_Target_1_Synonyms:
Beta-PGM
EC 5.4.2.6

# Drug_Target_1_Theoretical_pI:
4.60

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X85104

# Drug_Target_2_GenBank_ID_Protein:
728724

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
glnG

# Drug_Target_2_Gene_Sequence:
>1410 bp
ATGCAACGAGGAATAGTCTGGGTCGTCGATGATGATAGTTCCATCCGTTGGGTGCTTGAG
CGTGCTCTCGCCGGGGCAGGGTTGACCTGTACCACCTTTGAGAATGGTAATGAAGTACTG
GCTGCGCTGGCCAGTAAAACGCCGGACGTCTTGCTGTCGGATATCCGAATGCCGGGAATG
GACGGGCTGGCGCTATTAAAGCAGATTAAACAGCGTCACCCGATGCTTCCGGTCATCATT
ATGACCGCGCATTCCGATTTAGATGCCGCCGTGAGCGCCTATCAGCAGGGGGCGTTTGAT
TATCTGCCTAAACCGTTTGATATTGATGAAGCCGTCGCTCTGGTCGAGCGCGCGATTAGC
CACTATCAGGAGCAGCAACAGCCGCGTAATATCGAGGTTAACGGCCCGACAACAGACATG
ATAGGCGAAGCGCCCGCCATGCAGGATCTGTTTCGCATTATTGGTCGGCTGTCGCGTTCT
TCGATTAGCGTGCTGATTAACGGCGAATCAGGGACCGGTAAAGAACTGGTCGCCCATGCG
CTTCACCGCCATAGCCCACGCGCCAAAGCGCCGTTTATCGCACTCAATATGGCGGCCATC
CCGAAAGATTTGATTGAATCCGAACTGTTTGGCCATGAGAAAGGCGCTTTTACCGGGGCG
AATACCATCCGGCAGGGCCGTTTCGAGCAGGCTGACGGCGGCACGCTGTTTCTGGACGAA
ATTGGCGATATGCCGCTGGATGTCCAGACTCGTCTGTTACGCGTGCTGGCTGACGGACAG
TTCTACCGCGTGGGCGGGTACGCGCCGGTAAAAGTCGATGTGCGCATTATCGCCGCCACC
CACCAGAACCTCGAACGACGCGTTCAGGAAGGGAAATTCCGCGAAGACCTGTTCCACCGC
CTGAACGTGATTCGTATCCATCTTCCGCCGTTGCGTGAACGCCGTGAGGATATTCCGCGC
CTGGCGCGCCATTTTTTGCAGGTCGCCGCCCGTGAATTAGGCGTGGAAGCCAAATTATTA
CATCCGGAAACCGAAACGGCGTTAACGCGCCTGGCATGGCCTGGTAACGTGCGTCAGTTA
GAAAATACCTGCCGCTGGCTCACCGTCATGGCCGCCGGACAGGAGGTATTGATCCAGGAT
TTACCGGGCGAACTGTTTGAAGCCTCGACGCCGGATAGCCCGTCCCACCTGCCGCCGGAT
AGCTGGGCTACATTACTGGCACAATGGGCGGACCGCGCCTTGCGATCCGGTCATCAAAAC
CTGCTTTCTGAAGCGCAGCCAGAACTGGAGAGAACGCTACTGACCACGGCATTACGCCAT
ACGCAGGGTCATAAACAGGAAGCCGCCAGGCTGCTCGGTTGGGGGCGAAACACCCTAACG
CGGAAGTTGAAAGAGCTGGGAATGGAGTAA

# Drug_Target_2_General_Function:
Signal transduction mechanisms

# Drug_Target_2_General_References:
10512705	Pelton JG, Kustu S, Wemmer DE: Solution structure of the DNA-binding domain of NtrC with three alanine substitutions. J Mol Biol. 1999 Oct 8;292(5):1095-110.
10622255	Kern D, Volkman BF, Luginbuhl P, Nohaile MJ, Kustu S, Wemmer DE: Structure of a transiently phosphorylated switch in bacterial signal transduction. Nature. 1999 Dec 23-30;402(6764):894-8.
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
7602583	Flashner Y, Weiss DS, Keener J, Kustu S: Constitutive forms of the enhancer-binding protein NtrC: evidence that essential oligomerization determinants lie in the central activation domain. J Mol Biol. 1995 Jun 16;249(4):700-13.
7827089	Volkman BF, Nohaile MJ, Amy NK, Kustu S, Wemmer DE: Three-dimensional solution structure of the N-terminal receiver domain of NTRC. Biochemistry. 1995 Jan 31;34(4):1413-24.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2352

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
52272

# Drug_Target_2_Name:
Nitrogen regulation protein NR(I)

# Drug_Target_2_Number_of_Residues:
469

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00072	Response_reg
PF00158	Sigma54_activat
PF02954	HTH_8

# Drug_Target_2_Protein_Sequence:
>Nitrogen regulation protein NR(I)
MQRGIVWVVDDDSSIRWVLERALAGAGLTCTTFENGNEVLAALASKTPDVLLSDIRMPGM
DGLALLKQIKQRHPMLPVIIMTAHSDLDAAVSAYQQGAFDYLPKPFDIDEAVALVERAIS
HYQEQQQPRNIEVNGPTTDMIGEAPAMQDVFRIIGRLSRSSISVLINGESGTGKELVAHA
LHRHSPRAKAPFIALNMAAIPKDLIESELFGHEKGAFTGANTIRQGRFEQADGGTLFLDE
IGDMPLDVQTRLLRVLADGQFYRVGGYAPVKVDVRIIAATHQNLERRVQEGKFREDLFHR
LNVIRIHLPPLRERREDIPRLARHFLQVAARELGVEAKLLHPETETALTRLAWPGNVRQL
ENTCRWLTVMAAGQEVLIQDLPGELFEASTPDSPSHLPPDSWATLLAQWADRALRSGHQN
LLSEAQPELERTLLTTALRHTQGHKQEAARLLGWGRNTLTRKLKELGME

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Member of the two-component regulatory system ntrB/ntrC involved in the activation of nitrogen assimilatory genes such as glnA. NtrC is phosphorylated by ntrB and interacts with sigma-54

# Drug_Target_2_SwissProt_ID:
P41789

# Drug_Target_2_SwissProt_Name:
NTRC_SALTY

# Drug_Target_2_Synonyms:
I

# Drug_Target_2_Theoretical_pI:
6.62

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB01857
